We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

197 hedge funds and large institutions have $2.83B invested in NEVRO CORP. in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 68 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more call options, than puts

Call options by funds: $21.7M | Put options by funds: $6.48M

26% more capital invested

Capital invested by funds: $2.24B → $2.83B (+$592M)

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

2% more funds holding

Funds holding: 194197 (+3)

7% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 68

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
197
Holders Change
+3
Holders Change %
+1.55%
% of All Funds
4.52%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
29
Increased
63
Reduced
68
Closed
26
Calls
$21.7M
Puts
$6.48M
Net Calls
+$15.2M
Net Calls Change
+$14.9M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
101
T. Rowe Price Associates
Maryland
$1.19M -$2.81M -34,841 -72%
ACM
102
Asymmetry Capital Management
California
$1.13M -$864K -10,698 -45%
MIM
103
MetLife Investment Management
New Jersey
$1.13M
VOYA Investment Management
104
VOYA Investment Management
Georgia
$1.07M -$15.4K -191 -2%
SEI Investments
105
SEI Investments
Pennsylvania
$1.06M +$985K +12,199 +17,680%
Barclays
106
Barclays
United Kingdom
$1.04M -$827K -10,242 -46%
TAM
107
TFG Asset Management
Cayman Islands
$988K
GC
108
Grace Capital
Massachusetts
$980K -$862K -10,672 -49%
PCM
109
Prelude Capital Management
New York
$945K -$481K -5,958 -35%
ECM
110
Endurant Capital Management
California
$927K -$1.31M -16,260 -60%
BG
111
Bellevue Group
Switzerland
$927K
DIA
112
Denver Investment Advisors
Colorado
$916K +$55.6K +689 +7%
Legal & General Group
113
Legal & General Group
United Kingdom
$906K -$148K -1,831 -15%
GAM
114
Gotham Asset Management
New York
$834K +$777K +9,622 New
FMT
115
First Mercantile Trust
Tennessee
$792K -$91.1K -1,128 -11%
MLICM
116
Metropolitan Life Insurance Company (MetLife)
New York
$789K +$2.26K +28 +0.3%
UCFA
117
United Capital Financial Advisors
Texas
$760K -$27.1K -336 -4%
TAM
118
Trillium Asset Management
Massachusetts
$755K +$5.65K +70 +0.8%
Canada Pension Plan Investment Board
119
Canada Pension Plan Investment Board
Ontario, Canada
$745K +$694K +8,600 New
DekaBank Deutsche Girozentrale
120
DekaBank Deutsche Girozentrale
Germany
$690K -$928K -11,500 -59%
SO
121
STRS Ohio
Ohio
$669K +$64.6K +800 +12%
Royal Bank of Canada
122
Royal Bank of Canada
Ontario, Canada
$666K +$245K +3,035 +65%
GI
123
Gradient Investments
Minnesota
$575K +$102K +1,265 +24%
DC
124
Diametric Capital
Massachusetts
$544K -$68K -842 -12%
GI
125
GAMCO Investors
Connecticut
$520K

NVRO Hedge Fund Activity: Q1 2018 in Review

197 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2018, worth a combined $2.83B — up 26% from $2.24B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new NVRO positions and 26 closed out — a net gain of 3 holders — while 63 added to existing stakes and 68 trimmed.

The largest buyer was Millennium Management, adding an estimated $43.6M. The largest seller was Deutsche Bank, cutting an estimated $45.5M.

  • 197 institutional investors held NEVRO CORP. (NVRO) as of Q1 2018, up from 194 in Q4 2017.
  • Funds reported $2.83B of NEVRO CORP. stock for Q1 2018, up 26% quarter-over-quarter.
  • 29 funds opened new NEVRO CORP. positions in Q1 2018 and 26 closed out, a net change of +3 holders.
  • The largest NEVRO CORP. buyer in Q1 2018 was Millennium Management, an estimated $43.6M added.
  • The largest NEVRO CORP. seller in Q1 2018 was Deutsche Bank, an estimated $45.5M sold.

Based on aggregated 13F filings for Q1 2018.